Lymphokine-activated killer (LAK) cells against human leukemia: augmentation of LAK-cell cytotoxicity by combinations of lymphokines or cytokines.
Teichmann
J V
JV
Dept. of Hematology and Oncology, University-hospital Steglitz, Free University of Berlin, FRG.
Ludwig
W D
WD
Seibt-Jung
H
H
Thiel
E
E
D001685:Biological Factors / Q000494:pharmacology*; D016207:Cytokines; D003601:Cytotoxicity Tests, Immunologic; D004357:Drug Synergism; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D007938:Leukemia / Q000473:pathology*; D008222:Lymphokines / Q000494:pharmacology*; D011453:Prostaglandins / Q000502:physiology; D011994:Recombinant Proteins / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects*
D001685:Biological Factors; D016207:Cytokines; D008222:Lymphokines; D011453:Prostaglandins; D011994:Recombinant Proteins; D007213:Indomethacin